F

Fortrea Holdings Inc
NASDAQ:FTRE

Watchlist Manager
Fortrea Holdings Inc
NASDAQ:FTRE
Watchlist
Price: 16.91 USD -2.54% Market Closed
Market Cap: $1.6B

Operating Margin

-2.4%
Current
Declining
by 3%
vs 3-y average of 0.6%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-2.4%
=
Operating Income
$-67.4m
/
Revenue
$2.8B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-2.4%
=
Operating Income
$-67.4m
/
Revenue
$2.8B

Peer Comparison

Country Company Market Cap Operating
Margin
US
Fortrea Holdings Inc
NASDAQ:FTRE
1.6B USD
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
236.9B USD
Loading...
US
Danaher Corp
NYSE:DHR
165.5B USD
Loading...
CH
Lonza Group AG
SIX:LONN
37.6B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.1B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
279.2B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.2B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.8B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.3B EUR
Loading...

Market Distribution

In line with most companies in the United States of America
Percentile
33nd
Based on 14 112 companies
33nd percentile
-2.4%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Fortrea Holdings Inc
Glance View

Fortrea Holdings Inc. operates in the dynamic sphere of Contract Research Organizations (CRO), carving out a niche in the healthcare and biopharmaceutical industries by providing essential services to companies looking to bring new medicinal products and treatments to market. At its core, Fortrea specializes in conducting clinical trials, integrating advanced data analytics, and ensuring regulatory compliance, vital for pharmaceutical firms that often lack the infrastructure to manage these complex processes internally. By offering an array of services—from initial research design through to the final stages of clinical trials—Fortrea positions itself as a critical partner in the drug development lifecycle. This includes preclinical, clinical, and post-approval phases, ensuring that the medicines undergoing testing meet stringent safety and efficacy standards, which is a significant challenge in today's growing demand for faster time-to-market in healthcare innovation. What sets Fortrea apart from many in its industry is its strategic approach to integrating technology with clinical research, leveraging data-driven insights to streamline processes and improve the accuracy of research outcomes. The company generates revenue by entering into contracts with pharmaceutical and biotechnology companies, charging fees for specific research and trial services. Fortrea’s ability to provide tailored solutions that encompass the breadth of clinical services—from design and optimization of clinical studies to statistical analysis and project management—ensures consistent demand for its offerings. In a world where pharmaceutical innovation dictates market share and competitiveness, Fortrea's role in enabling breakthroughs in medical treatments positions it as a cornerstone of the healthcare research community, driving both its relevance and profitability.

FTRE Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-2.4%
=
Operating Income
$-67.4m
/
Revenue
$2.8B
What is Fortrea Holdings Inc's current Operating Margin?

The current Operating Margin for Fortrea Holdings Inc is -2.4%, which is below its 3-year median of 0.6%.

How has Operating Margin changed over time?

Over the last 3 years, Fortrea Holdings Inc’s Operating Margin has decreased from 7.9% to -2.4%. During this period, it reached a low of -4.1% on Dec 31, 2024 and a high of 7.9% on Mar 3, 2023.

Back to Top